This federal contract award, valued at $14,373.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the drug Thrombin-JMI, which is used for various medical applications. The contract is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of January 22, 2025. This contract award is part of a larger...
This federal contract award, valued at $14,329.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of THROMBIN-JMI, a medical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $5,928.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 contract vehicle that enables efficient procurement of essential pharmaceutical and medical supplies for military healthcare programs globally. The contract covers the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,357.48 firm-fixed-price delivery order is for the supply of 20,000 unit vials of the thrombin-jmi medication. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024 with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $7,902.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of Thrombin-JMI, a medical product, with a performance period ending on January 31, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,739.44 firm fixed-price delivery order is for the supply of 20,000 unit vials of Thrombin-JMI, a specialized blood coagulant product. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. The...
This federal contract award is for the delivery of THROMBIN-JMI 20,000 unit vials, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The $2,354.13 firm fixed-price delivery order has a completion date of December 12, 2023 and is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive...
This is a single federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20,000 unit vials of the pharmaceutical product Thrombin-JMI, with a ceiling value of $4,801.44 and a completion date of January 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award, with an ID of SPE2DB20D7061|SPE2DB25FSLH8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,490.87, is for the delivery of 5,000-unit vials of the medication Thrombin-JMI. This is a firm-fixed-price delivery order contract with a completion date of November 25, 2024. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,231.00 firm-fixed-price delivery order is for the supply of 5,000-unit vials of the pharmaceutical product Thrombin-JMI. The contract has a period of performance through September 25, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range...